AT
Alaunos Therapeutics Inc
🇺🇸XNAS.TCRTUnited StatesHealthcare
$2.42USDup +0.06 (+2.54%)OpenEnd of day6:54 PM
Price$2.42+0.06 (+2.54%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US98973P3091
- CUSIP
- 98973P101
Company
- Employees
- 1
- Headquarters
- Fort Lauderdale, United States
- Website
- https://www.alaunos.com
- CEO
- Mr. Holger Weis CPA
Market
- Shares outstanding
- 2.5M
- Market cap
- $5.81M
Highlights
- Market cap
- $5.81M
- EPS LTM
- -$1.58calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -1.53calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $3K-50%down year on year
- Net income
- -$4.01M-0.43%down year on year
- Gross margin
- -28,133.33%-152.32%down year on year
- Free cash flow
- -$2.82M+0.74%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.